Beigene Stock Current Liabilities
| BGNE Stock | USD 156.36 1.24 0.79% |
BeiGene fundamentals help investors to digest information that contributes to BeiGene's financial success or failures. It also enables traders to predict the movement of BeiGene Stock. The fundamental analysis module provides a way to measure BeiGene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BeiGene stock.
The current year's Total Current Liabilities is expected to grow to about 1.9 B, whereas Non Current Liabilities Total is forecasted to decline to about 372.9 M. BeiGene | Current Liabilities |
BeiGene Company Current Liabilities Analysis
BeiGene's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current BeiGene Current Liabilities | 35.17 M |
Most of BeiGene's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BeiGene is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
BeiGene Current Liabilities Driver Correlations
Understanding the fundamental principles of building solid financial models for BeiGene is extremely important. It helps to project a fair market value of BeiGene Stock properly, considering its historical fundamentals such as Current Liabilities. Since BeiGene's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BeiGene's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BeiGene's interrelated accounts and indicators.
Click cells to compare fundamentals
BeiGene Current Liabilities Historical Pattern
Today, most investors in BeiGene Stock are looking for potential investment opportunities by analyzing not only static indicators but also various BeiGene's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of BeiGene current liabilities as a starting point in their analysis.
BeiGene Current Liabilities |
| Timeline |
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
BeiGene Total Current Liabilities
Total Current Liabilities |
|
In accordance with the recently published financial statements, BeiGene has a Current Liabilities of 35.17 M. This is 97.99% lower than that of the Biotechnology sector and 93.52% lower than that of the Health Care industry. The current liabilities for all United States stocks is 99.55% higher than that of the company.
BeiGene Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BeiGene's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BeiGene could also be used in its relative valuation, which is a method of valuing BeiGene by comparing valuation metrics of similar companies.BeiGene is currently under evaluation in current liabilities category among its peers.
BeiGene Current Valuation Drivers
We derive many important indicators used in calculating different scores of BeiGene from analyzing BeiGene's financial statements. These drivers represent accounts that assess BeiGene's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of BeiGene's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 10.0B | 21.6B | 25.1B | 22.7B | 18.8B | 19.8B | |
| Enterprise Value | 9.6B | 20.7B | 21.5B | 19.7B | 16.6B | 17.4B |
BeiGene ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, BeiGene's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to BeiGene's managers, analysts, and investors.Environmental | Governance | Social |
BeiGene Fundamentals
| Return On Equity | -0.21 | ||||
| Return On Asset | -0.12 | ||||
| Profit Margin | (0.28) % | ||||
| Operating Margin | (0.35) % | ||||
| Current Valuation | 210.84 B | ||||
| Shares Outstanding | 113.43 M | ||||
| Shares Owned By Insiders | 19.79 % | ||||
| Shares Owned By Institutions | 49.71 % | ||||
| Number Of Shares Shorted | 1.67 M | ||||
| Price To Earning | (16.19) X | ||||
| Price To Book | 4.17 X | ||||
| Price To Sales | 6.34 X | ||||
| Revenue | 2.46 B | ||||
| Gross Profit | (511.06 M) | ||||
| EBITDA | (1.12 B) | ||||
| Net Income | (881.71 M) | ||||
| Cash And Equivalents | 5.7 B | ||||
| Cash Per Share | 55.17 X | ||||
| Total Debt | 930.18 M | ||||
| Debt To Equity | 0.12 % | ||||
| Current Ratio | 4.54 X | ||||
| Book Value Per Share | 32.13 X | ||||
| Cash Flow From Operations | (1.16 B) | ||||
| Short Ratio | 8.20 X | ||||
| Earnings Per Share | (7.54) X | ||||
| Target Price | 268.16 | ||||
| Number Of Employees | 10 K | ||||
| Beta | 0.6 | ||||
| Market Capitalization | 17.6 B | ||||
| Total Asset | 5.81 B | ||||
| Retained Earnings | (7.96 B) | ||||
| Working Capital | 2.39 B | ||||
| Current Asset | 106.27 M | ||||
| Current Liabilities | 35.17 M | ||||
| Net Asset | 5.81 B |
About BeiGene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BeiGene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BeiGene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BeiGene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in BeiGene Stock
When determining whether BeiGene is a strong investment it is important to analyze BeiGene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BeiGene's future performance. For an informed investment choice regarding BeiGene Stock, refer to the following important reports:Check out BeiGene Piotroski F Score and BeiGene Altman Z Score analysis. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeiGene. If investors know BeiGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeiGene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.54) | Revenue Per Share 26.458 | Quarterly Revenue Growth 0.679 | Return On Assets (0.12) | Return On Equity (0.21) |
The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own opinion of BeiGene's value that differs from its market value or its book value, called intrinsic value, which is BeiGene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeiGene's market value can be influenced by many factors that don't directly affect BeiGene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.